NCT04728217View on ClinicalTrials.gov

Health Related Quality of Life of Youth and Young Adults With Haemophilia A

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

February 20, 2023

Study Completion Date

February 20, 2023

Conditions
Hemophilia A
Interventions
DRUG

Efmoroctocog Alfa Injection [Eloctate]

Efmoroctocog alfa should be administered according to Summary of Product Characteristics (SmPC)/ Instruction on Medical Use approved by Russian Ministry of Health ЛП-006034 (13.01.2020).

Trial Locations (1)

119590

League of Clinical Research (LeagueCRR), Moscow

All Listed Sponsors
lead

The League of Clinical Research, Russia

OTHER